Target intelligence / Profile preview

Kelch-like protein 42 (KLHL42)

Target
KLHL42
Molecular classification
E3 ubiquitin ligase substrate adaptor, Carrier protein
01

Overview

Kelch-like protein 42 (KLHL42) is a substrate-specific adaptor of the BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex, which is necessary for mitotic progression and cytokinesis[3][4][5]. The BCR(KLHL42) E3 ubiquitin ligase complex specifically mediates the ubiquitination and subsequent degradation of KATNA1, influencing microtubule dynamics throughout mitosis[5]. KLHL42 has a role in proteasome-mediated ubiquitin-dependent protein catabolic processes and the regulation of microtubule-based processes. Mutations in KLHL42 have been associated with Bardet-Biedl syndrome and Eiken syndrome[3]. The protein contains conserved domains characteristic of the Kelch-like gene family, specifically a BTB/POZ domain, a BACK domain, and Kelch repeats, and functions in assembling multiprotein E3 ubiquitin ligase complexes[1][3].

Other names
Kelch like family member 42KLHL42KLHDC5 (previous symbol)
02

Mechanism of action

Drugs would typically act by modulating ubiquitination, affecting downstream protein stability and degradation

03

Biological functions

Ubiquitin-protein transferase activityProtein polyubiquitinationRegulation of microtubule-based processesMitotic progressionCytokinesisProtein degradation
04

Disease associations

Bardet-Biedl syndromeEiken syndromePossible roles in cancer and other disorders via protein ubiquitination pathway
05

Safety considerations

Potential for disrupting cell cycle and protein homeostasis if targeted, which could lead to toxicity or unintentional cell cycle arrest

Beyond the preview

Go deeper on Kelch-like protein 42 (KLHL42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 42 (KLHL42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call